, , , ,

CHICAGO — When Marathon Pharmaceuticals’ $89,000 price tag for a year’s supply of its newly approved muscular dystrophy drug sparked outrage earlier this month, the company’s CEO responded with another figure: $20. That’s how much he expected Duchenne muscular dystrophy patients would pay per prescription of the drug, he wrote in a letter posted on… https://omegapediatrics.com/pharma-firm-ceo-insists-89000-drug-affordable-true-cost/

Source: https://omegapediatrics.tumblr.com/post/157672737727